{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:47:31Z","timestamp":1780332451517,"version":"3.54.1"},"reference-count":197,"publisher":"Elsevier","isbn-type":[{"value":"9780443221729","type":"print"}],"license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/bs.ircmb.2024.05.002","type":"book-chapter","created":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T10:55:01Z","timestamp":1719744901000},"page":"53-94","source":"Crossref","is-referenced-by-count":11,"title":["Chemokine receptors in COVID-19 infection"],"prefix":"10.1016","author":[{"given":"Claudia","family":"Gutierrez-Chavez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalom","family":"Aperrigue-Lira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brando","family":"Ortiz-Saavedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irmia","family":"Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/bs.ircmb.2024.05.002_bib1","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.151571","article-title":"CD8+PD-L1+CXCR3+ polyfunctional T cell abundances are associated with survival in critical SARS-CoV-2\u2013infected patients","volume":"6","author":"Adam","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2021.100083","article-title":"Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: Case series of four critically ill patients treated with leronlimab","volume":"4","author":"Agresti","year":"2021","journal-title":"Journal of Translational Autoimmunity"},{"issue":"5","key":"10.1016\/bs.ircmb.2024.05.002_bib3","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.cell.2022.01.012","article-title":"A blood atlas of COVID-19 defines hallmarks of disease severity and specificity","volume":"185","author":"Ahern","year":"2022","journal-title":"Cell"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2022\/5545319","article-title":"Role of T regulatory cells and myeloid-derived suppressor cells in COVID-19","volume":"2022","author":"Alsalman","year":"2022","journal-title":"Journal of Immunology Research"},{"issue":"11","key":"10.1016\/bs.ircmb.2024.05.002_bib5","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1128\/AAC.49.11.4584-4591.2005","article-title":"TAK-652 inhibits CCR5-mediated human immunodeficiency virus type 1 infection in vitro and has favorable pharmacokinetics in humans","volume":"49","author":"Baba","year":"2005","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.113.007724","article-title":"International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors","volume":"66","author":"Bachelerie","year":"2014","journal-title":"Pharmacological Reviews"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1165\/rcmb.2009-0047TR","article-title":"Mechanisms of neutrophil accumulation in the lungs against bacteria","volume":"43","author":"Balamayooran","year":"2010","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.738687","article-title":"Unraveling risk genes of COVID-19 by multi-omics integrative analyses","volume":"8","author":"Baranova","year":"2021","journal-title":"Frontiers in Medicine"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib9","series-title":"International Review of Cell and Molecular Biology","doi-asserted-by":"crossref","DOI":"10.1016\/bs.ircmb.2024.02.003","article-title":"Role of chemokine receptors in gastrointestinal mucosa","author":"Bell","year":"2024"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.05.002_bib10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3390\/vaccines9020147","article-title":"SARS-CoV-2 mRNA vaccines: Immunological mechanism and beyond","volume":"9","author":"Bettini","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib11","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.3389\/fimmu.2020.02109","article-title":"The chemokine receptor CXCR4 in cell proliferation and tissue regeneration","volume":"11","author":"Bianchi","year":"2020","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib12","unstructured":"BioLineRx Ltd. (2020). BioLineRx announces initiation of phase 1b clinical trial in patients with acute respiratory distress syndrome (ARDS) secondary to COVID-19 and other respiratory viral infections. BioLineRx Ltd. https:\/\/ir.biolinerx.com\/news-releases\/news-release-details\/biolinerx-announces-initiation-phase-1b-clinical-trial-patients."},{"issue":"5","key":"10.1016\/bs.ircmb.2024.05.002_bib13","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced host response to SARS-CoV-2 drives development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib14","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1186\/s13054-020-03328-0","article-title":"CXCL10 could drive longer duration of mechanical ventilation during COVID-19 ARDS","volume":"24","author":"Blot","year":"2020","journal-title":"Critical Care"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib15","first-page":"17","article-title":"Eotaxin and CCR3 are up-regulated in exacerbations of chronic bronchitis: Eotaxin and CCR3 in chronic bronchitis","volume":"57","author":"Bocchino","year":"2002","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib16","doi-asserted-by":"crossref","first-page":"8306","DOI":"10.1038\/ncomms9306","article-title":"Functional classification of memory CD8+ T cells by CX3CR1 expression","volume":"6","author":"B\u00f6ttcher","year":"2015","journal-title":"Nature Communications"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.834862","article-title":"Comparison of lung-homing receptor expression and activation profiles on NK cell and T cell subsets in COVID-19 and influenza","volume":"13","author":"Brownlie","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"8","key":"10.1016\/bs.ircmb.2024.05.002_bib18","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s00018-023-04870-0","article-title":"Proteolytic inactivation of CXCL12 in the lungs and circulation of COVID-19 patients","volume":"80","author":"Cambier","year":"2023","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"10","key":"10.1016\/bs.ircmb.2024.05.002_bib19","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.3390\/ijms22105372","article-title":"Regulatory noncoding and predicted pathogenic coding variants of CCR5 predispose to severe COVID-19","volume":"22","author":"Cantalupo","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41579-022-00841-7","article-title":"SARS-CoV-2 variant biology: Immune escape, transmission and fitness","author":"Carabelli","year":"2023","journal-title":"Nature Reviews. Microbiology"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.05.002_bib21","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1053\/j.gastro.2011.09.015","article-title":"Gut-tropic T cells that express integrin \u03b14\u03b27 and CCR9 are required for induction of oral immune tolerance in mice","volume":"141","author":"Cassani","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib22","doi-asserted-by":"crossref","DOI":"10.1590\/0037-8682-0128-2023","article-title":"The CXCL9\/10\/11-CXCR3 axis as a predictor of COVID-19 progression: A prospective, case-control study","volume":"56","author":"\u00c7elik","year":"2023","journal-title":"Revista da Sociedade Brasileira de Medicina Tropical"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.05.002_bib23","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/cmi.2017.134","article-title":"Chemokines in homeostasis and diseases","volume":"15","author":"Chen","year":"2018","journal-title":"Cellular & Molecular Immunology"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib24","first-page":"1","article-title":"Recognition of immune cell markers of COVID-19 severity with machine learning methods","volume":"2022","author":"Chen","year":"2022","journal-title":"BioMed Research International"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib25","volume":"12","author":"Chiu","year":"2023","journal-title":"Emerging Microbes & Infections"},{"issue":"8","key":"10.1016\/bs.ircmb.2024.05.002_bib26","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/s41587-020-0602-4","article-title":"COVID-19 severity correlates with airway epithelium\u2013immune cell interactions identified by single-cell analysis","volume":"38","author":"Chua","year":"2020","journal-title":"Nature Biotechnology"},{"issue":"7","key":"10.1016\/bs.ircmb.2024.05.002_bib27","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.3390\/ijms25073788","article-title":"CC chemokine family members\u2019 modulation as a novel approach for treating central nervous system and peripheral nervous system injury\u2014A review of clinical and experimental findings","volume":"25","author":"Ciechanowska","year":"2024","journal-title":"International Journal of Molecular Sciences"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib28","series-title":"International review of cell and molecular biology","doi-asserted-by":"crossref","DOI":"10.1016\/bs.ircmb.2023.11.003","article-title":"Chemokine receptors in primary and secondary lymphoid tissues","author":"Cordero","year":"2024"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107825","article-title":"Variant-genetic and transcript-expression analysis showed a role for the chemokine-receptor CCR5 in COVID-19 severity","volume":"98","author":"Cuesta-Llavona","year":"2021","journal-title":"International Immunopharmacology"},{"issue":"9","key":"10.1016\/bs.ircmb.2024.05.002_bib30","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00439-021-02305-z","article-title":"Association of CXCR6 with COVID-19 severity: Delineating the host genetic factors in transcriptomic regulation","volume":"140","author":"Dai","year":"2021","journal-title":"Human Genetics"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib31","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1038\/s41467-020-17292-4","article-title":"Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia","volume":"11","author":"De Biasi","year":"2020","journal-title":"Nature Communications"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib32","doi-asserted-by":"crossref","DOI":"10.1177\/2040206619829382","article-title":"Mozobil\u00ae (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration","volume":"27","author":"De Clercq","year":"2019","journal-title":"Antiviral Chemistry and Chemotherapy"},{"issue":"10","key":"10.1016\/bs.ircmb.2024.05.002_bib33","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1164\/rccm.200608-1113OC","article-title":"Accumulation of dendritic cells and increased CCL20 levels in the airways of patients with chronic obstructive pulmonary disease","volume":"175","author":"Demedts","year":"2007","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.05.002_bib34","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3390\/vaccines11030699","article-title":"Regulatory T cells (Tregs) and COVID-19: Unveiling the mechanisms, and therapeutic potentialities with a special focus on long COVID","volume":"11","author":"Dhawan","year":"2023","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.05.002_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00367-20","article-title":"COVID-19 hyperinflammation: What about neutrophils?","volume":"5","author":"Didangelos","year":"2020","journal-title":"mSphere"},{"issue":"11","key":"10.1016\/bs.ircmb.2024.05.002_bib36","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1128\/AAC.49.11.4721-4732.2005","article-title":"Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity","volume":"49","author":"Dorr","year":"2005","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib37","series-title":"Contributions to microbiology","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000136317","article-title":"Antibacterial chemokines\u2014Actors in both innate and adaptive immunity","author":"Eliasson","year":"2008"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.05.002_bib38","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/jmv.20091","article-title":"Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5)","volume":"73","author":"Elliott","year":"2004","journal-title":"Journal of Medical Virology"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2021.100097","article-title":"Case study of a critically ill person with COVID-19 on ECMO successfully treated with leronlimab","volume":"4","author":"Elneil","year":"2021","journal-title":"Journal of Translational Autoimmunity"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109806","article-title":"T regulatory lymphocytes specific for SARS-CoV-2 display increased functional plasticity","volume":"256","author":"Esparcia-Pinedo","year":"2023","journal-title":"Clinical Immunology"},{"issue":"24","key":"10.1016\/bs.ircmb.2024.05.002_bib41","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1007\/s00018-019-03255-6","article-title":"Dual CCR5\/CCR2 targeting: Opportunities for the cure of complex disorders","volume":"76","author":"Fantuzzi","year":"2019","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib42","doi-asserted-by":"crossref","first-page":"6844","DOI":"10.1038\/s41467-021-27120-y","article-title":"Pediatric COVID-19 patients in South Brazil show abundant viral mRNA and strong specific anti-viral responses","volume":"12","author":"Fazolo","year":"2021","journal-title":"Nature Communications"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.771210","article-title":"Targeting the CCL2\/CCR2 axis in cancer immunotherapy: One stone, three birds?","volume":"12","author":"Fei","year":"2021","journal-title":"Frontiers in Immunology"},{"issue":"9","key":"10.1016\/bs.ircmb.2024.05.002_bib44","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1002\/jmv.27037","article-title":"Characterization of T lymphocytes in severe COVID\u201019 patients","volume":"93","author":"Fenoglio","year":"2021","journal-title":"Journal of Medical Virology"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.992743","article-title":"Immune responses in COVID-19 and tuberculosis coinfection: A scoping review","volume":"13","author":"Flores-Lovon","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109092","article-title":"Decrease in CD8+CD45+CCR7+CD62L+ T cells in individuals vaccinated with Sinovac-CoronaVac following COVID-19 infection","volume":"242","author":"Fonseca","year":"2022","journal-title":"Clinical Immunology"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib47","unstructured":"Food & Drug Administration. (2021). Statement on leronlimab. FDA. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/statement-leronlimab."},{"issue":"10","key":"10.1016\/bs.ircmb.2024.05.002_bib48","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.147535","article-title":"The relationship between cytokine and neutrophil gene network distinguishes SARS-CoV-2\u2013infected patients by sex and age","volume":"6","author":"Freire","year":"2021","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/bs.ircmb.2024.05.002_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1224","article-title":"Innate lymphoid cell composition associates with COVID\u201019 disease severity","volume":"9","author":"Garc\u00eda","year":"2020","journal-title":"Clinical & Translational Immunology"},{"issue":"7","key":"10.1016\/bs.ircmb.2024.05.002_bib50","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/cid\/ciac226","article-title":"Reduced cell surface levels of C-C chemokine receptor 5 and immunosuppression in long coronavirus disease 2019 syndrome","volume":"75","author":"Gaylis","year":"2022","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib51","unstructured":"GlycoMimetics, Inc. (2021). Positive findings from phase 1b trial of GlycoMimetics\u2019 GMI-1359 to be presented at AACR 2021 meeting. GlycoMimetics, Inc. https:\/\/ir.glycomimetics.com\/news-releases\/news-release-details\/positive-findings-phase-1b-trial-glycomimetics-gmi-1359-be."},{"issue":"10","key":"10.1016\/bs.ircmb.2024.05.002_bib52","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.3390\/v13101966","article-title":"Imbalanced immune response of T-cell and B-cell subsets in patients with moderate and severe COVID-19","volume":"13","author":"Golovkin","year":"2021","journal-title":"Viruses"},{"issue":"12","key":"10.1016\/bs.ircmb.2024.05.002_bib53","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1002\/eji.202149311","article-title":"SARS\u2010CoV2 pneumonia recovery is linked to expansion of innate lymphoid cells type 2 expressing CCR10","volume":"51","author":"Gomes","year":"2021","journal-title":"European Journal of Immunology"},{"issue":"12","key":"10.1016\/bs.ircmb.2024.05.002_bib54","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1172\/JCI141054","article-title":"Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals","volume":"130","author":"Gong","year":"2020","journal-title":"Journal of Clinical Investigation"},{"issue":"5","key":"10.1016\/bs.ircmb.2024.05.002_bib55","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.yexcr.2010.12.017","article-title":"CXCR3 in T cell function","volume":"317","author":"Groom","year":"2011","journal-title":"Experimental Cell Research"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1184014","article-title":"Development of tolerance to chemokine receptor antagonists: Current paradigms and the need for further investigation","volume":"14","author":"Grudzien","year":"2023","journal-title":"Frontiers in Immunology"},{"issue":"6511","key":"10.1016\/bs.ircmb.2024.05.002_bib57","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1126\/science.abc4730","article-title":"Adaptation of SARS-CoV-2 in BALB\/c mice for testing vaccine efficacy","volume":"369","author":"Gu","year":"2020","journal-title":"Science (New York, N. Y.)"},{"issue":"7","key":"10.1016\/bs.ircmb.2024.05.002_bib58","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.3390\/ijms23073673","article-title":"What is currently known about the role of CXCL10 in SARS-CoV-2 infection?","volume":"23","author":"Gudowska-Sawczuk","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.05.002_bib59","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.7150\/thno.15625","article-title":"Role of the CXCL8-CXCR1\/2 axis in cancer and inflammatory diseases","volume":"7","author":"Ha","year":"2017","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib60","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41392-023-01650-x","article-title":"SARS-CoV-2 spike-specific TFH cells exhibit unique responses in infected and vaccinated individuals","volume":"8","author":"He","year":"2023","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib61","unstructured":"HiDiH. (2021). CATCOVID (CCR1 antagonist treatment in patients hospitalized with COVID-19). HiDiH. https:\/\/www.hidih.org\/projects\/catcovid."},{"issue":"2","key":"10.1016\/bs.ircmb.2024.05.002_bib62","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1189\/jlb.3A0516-227R","article-title":"NK cells regulate CXCR2+ neutrophil recruitment during acute lung injury","volume":"101","author":"Hoegl","year":"2017","journal-title":"Journal of Leukocyte Biology"},{"issue":"5025","key":"10.1016\/bs.ircmb.2024.05.002_bib63","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1126\/science.1840701","article-title":"Structure and functional expression of a human interleukin-8 receptor","volume":"253","author":"Holmes","year":"1991","journal-title":"Science (New York, N. Y.)"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.05.002_bib64","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nature Reviews. Microbiology"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib65","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/jmv.26232","article-title":"The cytokine storm and COVID\u201019","volume":"93","author":"Hu","year":"2021","journal-title":"Journal of Medical Virology"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib66","doi-asserted-by":"crossref","first-page":"111","DOI":"10.33549\/physiolres.934647","article-title":"CCR5\u039432 deletion as a protective factor in czech first-wave COVID-19 subjects","author":"Hubacek","year":"2021","journal-title":"Physiological Research"},{"issue":"16","key":"10.1016\/bs.ircmb.2024.05.002_bib67","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"The FEBS Journal"},{"issue":"10","key":"10.1016\/bs.ircmb.2024.05.002_bib68","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.jid.2020.02.023","article-title":"Pivotal involvement of the CX3CL1-CX3CR1 axis for the recruitment of M2 tumor-associated macrophages in skin carcinogenesis","volume":"140","author":"Ishida","year":"2020","journal-title":"Journal of Investigative Dermatology"},{"issue":"5","key":"10.1016\/bs.ircmb.2024.05.002_bib69","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.yexcr.2010.12.018","article-title":"CCR6 as a mediator of immunity in the lung and gut","volume":"317","author":"Ito","year":"2011","journal-title":"Experimental Cell Research"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib70","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s43587-022-00343-4","article-title":"Impaired CD4+ T cell response in older adults is associated with reduced immunogenicity and reactogenicity of mRNA COVID-19 vaccination","volume":"3","author":"Jo","year":"2023","journal-title":"Nature Aging"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.05.002_bib71","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.4049\/jimmunol.175.4.2702","article-title":"CCR3 expression and function in asthmatic airway smooth muscle cells","volume":"175","author":"Joubert","year":"2005","journal-title":"The Journal of Immunology"},{"issue":"18","key":"10.1016\/bs.ircmb.2024.05.002_bib72","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.150862","article-title":"Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19","volume":"6","author":"Kaiser","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib73","unstructured":"Kancer, A. B. (n.d.). KAND567\u2014A candidate to counteract hyperinflammation in COVID-19 and heart attack. Biopharma Dealmakers. https:\/\/www.nature.com\/articles\/d43747\u2013020-01156\u20133."},{"issue":"6","key":"10.1016\/bs.ircmb.2024.05.002_bib74","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nm1245","article-title":"Reversing systemic inflammatory response syndrome with chemokine receptor pepducins","volume":"11","author":"Kaneider","year":"2005","journal-title":"Nature Medicine"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.05.002_bib75","doi-asserted-by":"crossref","first-page":"00583","DOI":"10.1183\/23120541.00583-2020","article-title":"CXCL-8-dependent and -independent neutrophil activation in COPD: Experiences from a pilot study of the CXCR2 antagonist danirixin","volume":"6","author":"Keir","year":"2020","journal-title":"ERJ Open Research"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.05.002_bib76","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1093\/micmic\/ozad129","article-title":"SARS-CoV-2 causes brain damage: Therapeutic intervention with AZD8797","volume":"29","author":"Kervancioglu Demirci","year":"2023","journal-title":"Microscopy and Microanalysis"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib77","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.csbj.2021.01.034","article-title":"Chemokines and chemokine receptors during COVID-19 infection","volume":"19","author":"Khalil","year":"2021","journal-title":"Computational and Structural Biotechnology Journal"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.957913","article-title":"The striking mimics between COVID-19 and malaria: A review","volume":"13","author":"Konozy","year":"2022","journal-title":"Frontiers in Immunology"},{"issue":"16","key":"10.1016\/bs.ircmb.2024.05.002_bib79","doi-asserted-by":"crossref","first-page":"9058","DOI":"10.3390\/ijms23169058","article-title":"A comparative study of the plasma chemokine profile in COVID-19 patients infected with different SARS-CoV-2 variants","volume":"23","author":"Korobova","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.05.002_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2021.100208","article-title":"Integrated immune dynamics define correlates of COVID-19 severity and antibody responses","volume":"2","author":"Koutsakos","year":"2021","journal-title":"Cell Reports Medicine"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib81","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/s41541-023-00724-9","article-title":"Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cells","volume":"8","author":"Krause","year":"2023","journal-title":"Npj Vaccines"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib82","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3390\/cimb44010014","article-title":"Alterations in B cell and follicular T-helper cell subsets in patients with acute COVID-19 and COVID-19 convalescents","volume":"44","author":"Kudryavtsev","year":"2021","journal-title":"Current Issues in Molecular Biology"},{"issue":"9","key":"10.1016\/bs.ircmb.2024.05.002_bib83","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.3390\/v14091906","article-title":"Heterogenous CD8+ T cell maturation and \u2018polarization\u2019 in acute and convalescent COVID-19 patients","volume":"14","author":"Kudryavtsev","year":"2022","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.05.002_bib84","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/icb.2015.15","article-title":"Chemokine and chemokine receptor structure and interactions: Implications for therapeutic strategies","volume":"93","author":"Kufareva","year":"2015","journal-title":"Immunology & Cell Biology"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib85","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jaut.2017.10.013","article-title":"CCR6 signaling inhibits suppressor function of induced-Treg during gut inflammation","volume":"88","author":"Kulkarni","year":"2018","journal-title":"Journal of Autoimmunity"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib86","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jgar.2022.12.004","article-title":"Cenicriviroc for the treatment of COVID-19: First interim results of a randomised, placebo-controlled, investigator-initiated, double-blind phase II trial","volume":"32","author":"Kurth","year":"2023","journal-title":"Journal of Global Antimicrobial Resistance"},{"issue":"10","key":"10.1016\/bs.ircmb.2024.05.002_bib87","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1038\/s41591-020-1038-6","article-title":"A dynamic COVID-19 immune signature includes associations with poor prognosis","volume":"26","author":"Laing","year":"2020","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib88","doi-asserted-by":"crossref","DOI":"10.1007\/s40121-022-00644-6","article-title":"A multicenter phase 2 randomized controlled study on the efficacy and safety of reparixin in the treatment of hospitalized patients with COVID-19 pneumonia","author":"Landoni","year":"2022","journal-title":"Infectious Diseases and Therapy"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib89","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12931-020-01401-4","article-title":"CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: A phase 2b trial","volume":"21","author":"Lazaar","year":"2020","journal-title":"Respiratory Research"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.05.002_bib90","first-page":"95","article-title":"Chemokines and chemokine receptors: Their manifold roles in homeostasis and disease","volume":"1","author":"Le","year":"2004","journal-title":"Cellular & Molecular Immunology"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.05.002_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158156","article-title":"Antifibrotic effects of the dual CCR2\/CCR5 antagonist cenicriviroc in animal models of liver and kidney fibrosis","volume":"11","author":"Lefebvre","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib92","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.molimm.2019.11.014","article-title":"Chemokines and their receptors promoting the recruitment of myeloid-derived suppressor cells into the tumor","volume":"117","author":"Li","year":"2020","journal-title":"Molecular Immunology"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib93","article-title":"The autocrine CXCR4\/CXCL12 axis contributes to lung fibrosis through modulation of lung fibroblast activity","author":"Li","year":"2020","journal-title":"Experimental and Therapeutic Medicine"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.05.002_bib94","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/s41418-022-01015-x","article-title":"Immune response in COVID-19: What is next?","volume":"29","author":"Li","year":"2022","journal-title":"Cell Death & Differentiation"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib95","doi-asserted-by":"crossref","first-page":"7255","DOI":"10.1038\/s41467-022-34638-2","article-title":"Immune phenotypes that are associated with subsequent COVID-19 severity inferred from post-recovery samples","volume":"13","author":"Liechti","year":"2022","journal-title":"Nature Communications"},{"issue":"7","key":"10.1016\/bs.ircmb.2024.05.002_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112780","article-title":"Tracking B cell responses to the SARS-CoV-2 mRNA-1273 vaccine","volume":"42","author":"Lopes De Assis","year":"2023","journal-title":"Cell Reports"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib97","series-title":"International review of cell and molecular biology","doi-asserted-by":"crossref","DOI":"10.1016\/bs.ircmb.2024.03.008","article-title":"Chemotactic signaling pathways in prostate cancer: Implications in the tumor microenvironment and as potential therapeutic targets","author":"Lopez-Bujanda","year":"2024"},{"issue":"40","key":"10.1016\/bs.ircmb.2024.05.002_bib98","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2109123118","article-title":"High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19","volume":"118","author":"Lourda","year":"2021","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"22","key":"10.1016\/bs.ircmb.2024.05.002_bib99","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1158\/0008-5472.CAN-16-0984","article-title":"CCR2 influences T regulatory cell migration to tumors and serves as a biomarker of cyclophosphamide sensitivity","volume":"76","author":"Loyher","year":"2016","journal-title":"Cancer Research"},{"issue":"5","key":"10.1016\/bs.ircmb.2024.05.002_bib100","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/pai.13267","article-title":"SARS\u2010CoV\u20102 infection in children\u2014Understanding the immune responses and controlling the pandemic","volume":"31","author":"Lu","year":"2020","journal-title":"Pediatric Allergy and Immunology"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.05.002_bib101","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/cei\/uxad044","article-title":"Plasmablasts in previously immunologically na\u00efve COVID-19 patients express markers indicating mucosal homing and secrete antibodies cross-reacting with SARS-CoV-2 variants and other beta-coronaviruses","volume":"213","author":"Lundgren","year":"2023","journal-title":"Clinical and Experimental Immunology"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib102","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13073-022-01021-1","article-title":"Integrating single-cell sequencing data with GWAS summary statistics reveals CD16+monocytes and memory CD8+T cells involved in severe COVID-19","volume":"14","author":"Ma","year":"2022","journal-title":"Genome Medicine"},{"issue":"3_Supplement","key":"10.1016\/bs.ircmb.2024.05.002_bib103","article-title":"Abstract B2: Coexpression of effector T cell-associated chemokine receptors defines T-cell subsets with different roles in antitumor response and toxicity of dual checkpoint blockade","volume":"8","author":"Macedo","year":"2020","journal-title":"Cancer Immunology Research"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010176","article-title":"Hyperinflammatory environment drives dysfunctional myeloid cell effector response to bacterial challenge in COVID-19","volume":"18","author":"Mairpady Shambat","year":"2022","journal-title":"PLoS Pathogens"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.600369","article-title":"Chemokine regulation during epidemic coronavirus infection","volume":"11","author":"Majumdar","year":"2021","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.566953","article-title":"CXCR1 and CXCR2 inhibition by ladarixin improves neutrophil-dependent airway inflammation in mice","volume":"11","author":"Mattos","year":"2020","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib107","doi-asserted-by":"crossref","first-page":"180","DOI":"10.12688\/f1000research.143776.2","article-title":"Effect of Maraviroc and\/or Favipiravir plus systemic steroids versus systemic steroids only on the viral load of adults with severe COVID-19: Clinical trial","volume":"13","author":"Medina","year":"2024","journal-title":"F1000Research"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.05.002_bib108","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1271","article-title":"Kinetics of peripheral blood neutrophils in severe coronavirus disease 2019","volume":"10","author":"Metzemaekers","year":"2021","journal-title":"Clinical & Translational Immunology"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib109","series-title":"Rheumatoid arthritis","first-page":"372","article-title":"Promising biologic agents and small chemical compounds","author":"Meyer","year":"2009"},{"issue":"9","key":"10.1016\/bs.ircmb.2024.05.002_bib110","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1084\/jem.20130091","article-title":"Lung dendritic cells imprint T cell lung homing and promote lung immunity through the chemokine receptor CCR4","volume":"210","author":"Mikhak","year":"2013","journal-title":"Journal of Experimental Medicine"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.05.002_bib111","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3390\/biomedicines10030549","article-title":"The role of genetic factors in the development of acute respiratory viral infection COVID-19: Predicting severe course and outcomes","volume":"10","author":"Minashkin","year":"2022","journal-title":"Biomedicines"},{"issue":"11","key":"10.1016\/bs.ircmb.2024.05.002_bib112","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.4049\/jimmunol.2200525","article-title":"Memory B cells and memory T cells induced by SARS-CoV-2 booster vaccination or infection show different dynamics and responsiveness to the omicron variant","volume":"209","author":"Mise-Omata","year":"2022","journal-title":"The Journal of Immunology"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.05.002_bib113","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/s41590-023-01445-w","article-title":"Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course","volume":"24","author":"Muri","year":"2023","journal-title":"Nature Immunology"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib114","series-title":"Clinical immunology","first-page":"157","article-title":"Chemokines and chemokine receptors","author":"Murphy","year":"2019"},{"issue":"5025","key":"10.1016\/bs.ircmb.2024.05.002_bib115","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1126\/science.1891716","article-title":"Cloning of complementary DNA encoding a functional human interleukin-8 receptor","volume":"253","author":"Murphy","year":"1991","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib116","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3389\/fphar.2020.00870","article-title":"Neutrophilia and NETopathy as key pathologic drivers of progressive lung impairment in patients with COVID-19","volume":"11","author":"Narasaraju","year":"2020","journal-title":"Frontiers in Pharmacology"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.05.002_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109414","article-title":"Distinctive features of SARS-CoV-2-specific T cells predict recovery from severe COVID-19","volume":"36","author":"Neidleman","year":"2021","journal-title":"Cell Reports"},{"issue":"7875","key":"10.1016\/bs.ircmb.2024.05.002_bib118","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-021-03841-4","article-title":"Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine","volume":"597","author":"Oberhardt","year":"2021","journal-title":"Nature"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.05.002_bib119","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1001\/jama.2023.11043","article-title":"Abatacept, cenicriviroc, or infliximab for treatment of adults hospitalized with COVID-19 pneumonia: A randomized clinical trial","volume":"330","author":"O\u2019Halloran","year":"2023","journal-title":"JAMA: The Journal of the American Medical Association"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104902","article-title":"The chemokine receptor antagonist cenicriviroc inhibits the replication of SARS-CoV-2 in vitro","volume":"182","author":"Okamoto","year":"2020","journal-title":"Antiviral Research"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib121","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2147\/OTT.S165615","article-title":"Mogamulizumab: A new tool for management of cutaneous T-cell lymphoma","volume":"Vol. 12","author":"Ollila","year":"2019","journal-title":"OncoTargets and Therapy"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.05.002_bib122","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jcmgh.2021.04.006","article-title":"The heteromeric complex formed by dopamine receptor D5 and CCR9 leads the gut homing of CD4+ T cells upon inflammation","volume":"12","author":"Osorio-Barrios","year":"2021","journal-title":"Cellular and Molecular Gastroenterology and Hepatology"},{"issue":"7848","key":"10.1016\/bs.ircmb.2024.05.002_bib123","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41586-020-03065-y","article-title":"Genetic mechanisms of critical illness in COVID-19","volume":"591","author":"Pairo-Castineira","year":"2021","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib124","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.700782","article-title":"Immune-based prediction of COVID-19 severity and chronicity decoded using machine learning","volume":"12","author":"Patterson","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijid.2020.10.101","article-title":"CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14","volume":"103","author":"Patterson","year":"2021","journal-title":"International Journal of Infectious Diseases"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib126","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1122529","article-title":"Case series: Maraviroc and pravastatin as a therapeutic option to treat long COVID\/Post-acute sequelae of COVID (PASC)","volume":"10","author":"Patterson","year":"2023","journal-title":"Frontiers in Medicine"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib127","article-title":"A randomized, controlled study on the safety and efficacy of maraviroc and\/or favipiravir vs currently used therapy in severe COVID-19 adults","author":"P\u00e9rez-Garc\u00eda","year":"2021","journal-title":"\u201cCOMVIVIR\u201d trial"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109024","article-title":"Myeloid-derived suppressor cells in COVID-19: A review","volume":"238","author":"Perfilyeva","year":"2022","journal-title":"Clinical Immunology"},{"issue":"10","key":"10.1016\/bs.ircmb.2024.05.002_bib129","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1007\/s40121-023-00871-5","article-title":"Efficacy and safety of reparixin in patients with severe COVID-19 pneumonia: A phase 3, randomized, double-blind placebo-controlled study","volume":"12","author":"Piemonti","year":"2023","journal-title":"Infectious Diseases and Therapy"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib130","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.873596","article-title":"The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis","volume":"10","author":"Rahmani","year":"2022","journal-title":"Frontiers in Public Health"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.05.002_bib131","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1201248","article-title":"Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease","volume":"367","author":"Reshef","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.05.002_bib132","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009416","article-title":"Viral genomic, metagenomic and human transcriptomic characterization and prediction of the clinical forms of COVID-19","volume":"17","author":"Rodriguez","year":"2021","journal-title":"PLoS Pathogens"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib133","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jaci.2020.09.009","article-title":"Compartmental immunophenotyping in COVID-19 ARDS: A case series","volume":"147","author":"Ronit","year":"2021","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"10","key":"10.1016\/bs.ircmb.2024.05.002_bib134","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/s41419-020-03125-1","article-title":"Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome","volume":"11","author":"Sacchi","year":"2020","journal-title":"Cell Death & Disease"},{"issue":"12","key":"10.1016\/bs.ircmb.2024.05.002_bib135","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.3390\/biomedicines9121794","article-title":"COVID-19 specific immune markers revealed by single cell phenotypic profiling","volume":"9","author":"Sansico","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib136","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.85009","article-title":"Prolonged T-cell activation and long COVID symptoms independently associate with severe COVID-19 at 3 months","volume":"12","author":"Santopaolo","year":"2023","journal-title":"eLife"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.05.002_bib137","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/eji.202049046","article-title":"Enrichment of CCR6 + CD8 + T cells and CCL20 in the lungs of mechanically ventilated patients with COVID\u201019","volume":"51","author":"Saris","year":"2021","journal-title":"European Journal of Immunology"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib138","doi-asserted-by":"crossref","first-page":"6760","DOI":"10.1038\/s41467-021-26888-3","article-title":"COVID-19 genetic risk variants are associated with expression of multiple genes in diverse immune cell types","volume":"12","author":"Schmiedel","year":"2021","journal-title":"Nature Communications"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib139","series-title":"A phase 2 study of leronlimab for mild to moderate coronavirus disease 2019 (COVID-19)","author":"Seethamraju","year":"2020"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib140","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41467-020-20642-x","article-title":"SARS-CoV-2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques","volume":"12","author":"Shaan Lakshmanappa","year":"2021","journal-title":"Nature Communications"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.05.002_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2022.152184","article-title":"CCR2 and DPP9 expression in the peripheral blood of COVID-19 patients: Influences of the disease severity and gender","volume":"227","author":"Sharif-zak","year":"2022","journal-title":"Immunobiology"},{"issue":"12","key":"10.1016\/bs.ircmb.2024.05.002_bib142","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000240","article-title":"MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV","volume":"4","author":"Sheahan","year":"2008","journal-title":"PLoS Pathogens"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.05.002_bib143","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s10753-017-0538-0","article-title":"Effects of SDF-1\/CXCR4 on acute lung injury induced by cardiopulmonary bypass","volume":"40","author":"Shi","year":"2017","journal-title":"Inflammation"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.05.002_bib144","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.cell.2020.08.002","article-title":"Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19","volume":"182","author":"Silvin","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.05.002_bib145","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/iid3.476","article-title":"Sustained expression of inflammatory monocytes and activated T cells in COVID\u201019 patients and recovered convalescent plasma donors","volume":"9","author":"Singh","year":"2021","journal-title":"Immunity, Inflammation and Disease"},{"issue":"19","key":"10.1016\/bs.ircmb.2024.05.002_bib146","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1182\/blood-2010-07-295626","article-title":"CCR6\/CCR10-mediated plasmacytoid dendritic cell recruitment to inflamed epithelia after instruction in lymphoid tissues","volume":"118","author":"Sisirak","year":"2011","journal-title":"Blood"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155810","article-title":"Elevated plasma levels of CXCL16 in severe COVID-19 patients","volume":"152","author":"Smieszek","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib148","series-title":"Encyclopedia of biological chemistry","first-page":"480","article-title":"Chemokine receptors","author":"Sobolik-Delmaire","year":"2013"},{"issue":"5","key":"10.1016\/bs.ircmb.2024.05.002_bib149","doi-asserted-by":"crossref","first-page":"a016303","DOI":"10.1101\/cshperspect.a016303","article-title":"The chemokine system in innate immunity","volume":"7","author":"Sokol","year":"2015","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.05.002_bib150","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2217902120","article-title":"A sex-biased imbalance between Tfr, Tph, and atypical B cells determines antibody responses in COVID-19 patients","volume":"120","author":"S\u00f8ndergaard","year":"2023","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.05.002_bib151","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1002\/eji.202049135","article-title":"Upregulation of CCR4 in activated CD8+ T cells indicates enhanced lung homing in patients with severe acute SARS\u2010CoV\u20102 infection","volume":"51","author":"Spoerl","year":"2021","journal-title":"European Journal of Immunology"},{"issue":"3","key":"10.1016\/bs.ircmb.2024.05.002_bib152","doi-asserted-by":"crossref","first-page":"2002182","DOI":"10.1183\/13993003.02182-2020","article-title":"Potential of regulatory T-cell-based therapies in the management of severe COVID-19","volume":"56","author":"Stephen-Victor","year":"2020","journal-title":"European Respiratory Journal"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.05.002_bib153","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3390\/cells12020244","article-title":"Influence of SARS-CoV-2 on adult human neurogenesis","volume":"12","author":"St\u0119pie\u0144","year":"2023","journal-title":"Cells"},{"issue":"577","key":"10.1016\/bs.ircmb.2024.05.002_bib154","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd2223","article-title":"IgA dominates the early neutralizing antibody response to SARS-CoV-2","volume":"13","author":"Sterlin","year":"2021","journal-title":"Science Translational Medicine"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib155","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13059-022-02669-z","article-title":"Severe COVID-19-associated variants linked to chemokine receptor gene control in monocytes and macrophages","volume":"23","author":"Stikker","year":"2022","journal-title":"Genome Biology"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.05.002_bib156","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s10753-020-01235-8","article-title":"The complexity of targeting chemokines to promote a tumor immune response","volume":"43","author":"Strazza","year":"2020","journal-title":"Inflammation"},{"issue":"12","key":"10.1016\/bs.ircmb.2024.05.002_bib157","doi-asserted-by":"crossref","first-page":"6059","DOI":"10.4049\/jimmunol.1201606","article-title":"CXCR3 deficiency prolongs Th1-type contact hypersensitivity","volume":"190","author":"Suga","year":"2013","journal-title":"The Journal of Immunology"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.145145","article-title":"Serum CCL17 level becomes a predictive marker to distinguish between mild\/moderate and severe\/critical disease in patients with COVID-19","volume":"766","author":"Sugiyama","year":"2021","journal-title":"Gene"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib159","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-21620-7","article-title":"A molecular signature of lung-resident CD8+ T cells elicited by subunit vaccination","volume":"12","author":"Suryadevara","year":"2022","journal-title":"Scientific Reports"},{"issue":"5","key":"10.1016\/bs.ircmb.2024.05.002_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.xcrm.2022.100631","article-title":"Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccine","volume":"3","author":"Takano","year":"2022","journal-title":"Cell Reports Medicine"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib161","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/07853890.2020.1858234","article-title":"Increased expression of hypoxia-induced factor 1\u03b1 mRNA and its related genes in myeloid blood cells from critically ill COVID-19 patients","volume":"53","author":"Taniguchi-Ponciano","year":"2021","journal-title":"Annals of Medicine"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib162","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.3389\/fimmu.2017.01799","article-title":"CXCR1\/2 antagonism is protective during influenza and post-influenza pneumococcal infection","volume":"8","author":"Tavares","year":"2017","journal-title":"Frontiers in Immunology"},{"issue":"4","key":"10.1016\/bs.ircmb.2024.05.002_bib163","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41577-021-00526-x","article-title":"COVID-19 vaccines: Modes of immune activation and future challenges","volume":"21","author":"Teijaro","year":"2021","journal-title":"Nature Reviews. Immunology"},{"issue":"16","key":"10.1016\/bs.ircmb.2024.05.002_bib164","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa2020283","article-title":"Genomewide association study of severe Covid-19 with respiratory failure","volume":"383","author":"The Severe Covid-19. Group","year":"2020","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib165","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ctrv.2017.11.007","article-title":"CXCL9, CXCL10, CXCL11\/CXCR3 axis for immune activation\u2014A target for novel cancer therapy","volume":"63","author":"Tokunaga","year":"2018","journal-title":"Cancer Treatment Reviews"},{"issue":"7","key":"10.1016\/bs.ircmb.2024.05.002_bib166","first-page":"L603","article-title":"Chemokine receptors and their therapeutic opportunities in diseased lung: Far beyond leukocyte trafficking","volume":"308","author":"Tomankova","year":"2015","journal-title":"American Journal of"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib167","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2174\/1875044300801010076","article-title":"Potential role of CC chemokines and their receptors in the development of respiratory diseases","volume":"1","author":"Tong","year":"2009","journal-title":"Journal of Epithelial Biology & Pharmacology"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.05.002_bib168","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41587-020-00796-1","article-title":"Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19","volume":"39","author":"Trump","year":"2021","journal-title":"Nature Biotechnology"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.05.002_bib169","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02749-21","article-title":"CCR2 signaling restricts SARS-CoV-2 infection","volume":"12","author":"Vanderheiden","year":"2021","journal-title":"mBio"},{"issue":"6","key":"10.1016\/bs.ircmb.2024.05.002_bib170","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/bfgp\/elac033","article-title":"Genome-wide mendelian randomization and single-cell RNA sequencing analyses identify the causal effects of COVID-19 on 41 cytokines","volume":"21","author":"Wang","year":"2022","journal-title":"Briefings in Functional Genomics"},{"issue":"7","key":"10.1016\/bs.ircmb.2024.05.002_bib171","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.3390\/genes13071109","article-title":"Identification of COVID-19-associated DNA methylation variations by integrating methylation array and scRNA-Seq data at cell-type resolution","volume":"13","author":"Wang","year":"2022","journal-title":"Genes"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib172","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41392-022-00978-0","article-title":"SARS-CoV-2-specific CD4+ T cells are associated with long-term persistence of neutralizing antibodies","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"29","key":"10.1016\/bs.ircmb.2024.05.002_bib173","doi-asserted-by":"crossref","first-page":"22313","DOI":"10.1074\/jbc.M001461200","article-title":"Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2)","volume":"275","author":"Wang","year":"2000","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib174","unstructured":"WHO. (2022). Middle East respiratory syndrome coronavirus (MERS-CoV). World Health Organization. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/middle-east-respiratory-syndrome-coronavirus-(mers-cov)."},{"key":"10.1016\/bs.ircmb.2024.05.002_bib175","unstructured":"WHO. (2023a). Coronavirus disease (COVID-19). World Health Organization. https:\/\/www.who.int\/health-topics\/coronavirus#tab=tab_1."},{"key":"10.1016\/bs.ircmb.2024.05.002_bib176","unstructured":"WHO. (2023b). Severe acute respiratory syndrome (SARS). World Health Organization. https:\/\/www.who.int\/health-topics\/severe-acute-respiratory-syndrome#tab=tab_1."},{"key":"10.1016\/bs.ircmb.2024.05.002_bib177","unstructured":"WHO. (2023c). WHO Coronavirus (COVID-19) dashboard. World Health Organization. https:\/\/data.who.int\/dashboards\/covid19\/cases."},{"key":"10.1016\/bs.ircmb.2024.05.002_bib178","series-title":"Encyclopedia of respiratory medicine","first-page":"332","article-title":"Chemokines: CC family","author":"Williams","year":"2022"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib179","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1165\/rcmb.2006-0457OC","article-title":"Intracellular signaling mechanisms regulating toll-like receptor\u2013mediated activation of eosinophils","volume":"37","author":"Wong","year":"2007","journal-title":"American Journal of Respiratory Cell and Molecular Biology"},{"issue":"5","key":"10.1016\/bs.ircmb.2024.05.002_bib180","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/s41590-022-01175-5","article-title":"Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory","volume":"23","author":"Wragg","year":"2022","journal-title":"Nature Immunology"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib181","article-title":"The roles of CCR9\/CCL25 in inflammation and inflammation-associated diseases","volume":"9","author":"Wu","year":"2021","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"8","key":"10.1016\/bs.ircmb.2024.05.002_bib182","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s13238-012-2927-3","article-title":"CCR10 and its ligands in regulation of epithelial immunity and diseases","volume":"3","author":"Xiong","year":"2012","journal-title":"Protein & Cell"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib183","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/22221751.2020.1747363","article-title":"Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients","volume":"9","author":"Xiong","year":"2020","journal-title":"Emerging Microbes & Infections"},{"issue":"10","key":"10.1016\/bs.ircmb.2024.05.002_bib184","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13115","article-title":"Role of the CCL2\u2010CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting","volume":"54","author":"Xu","year":"2021","journal-title":"Cell Proliferation"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib185","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107975","article-title":"Astrocyte-derived CCL7 promotes microglia-mediated inflammation following traumatic brain injury","volume":"99","author":"Xue","year":"2021","journal-title":"International Immunopharmacology"},{"issue":"12","key":"10.1016\/bs.ircmb.2024.05.002_bib186","doi-asserted-by":"crossref","first-page":"8391","DOI":"10.4049\/jimmunol.181.12.8391","article-title":"CCR6 regulates the migration of inflammatory and regulatory T cells","volume":"181","author":"Yamazaki","year":"2008","journal-title":"The Journal of Immunology"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib187","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/intimm\/dxu079","article-title":"CCR4 and its ligands: From bench to bedside","volume":"27","author":"Yoshie","year":"2015","journal-title":"International Immunology"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib188","series-title":"xPharm: The comprehensive pharmacology reference","first-page":"1","article-title":"CCR9 chemokine receptor","author":"Zaballos","year":"2007"},{"issue":"2","key":"10.1016\/bs.ircmb.2024.05.002_bib189","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41423-018-0187-8","article-title":"CCR2 enhances CD25 expression by FoxP3+ regulatory T cells and regulates their abundance independently of chemotaxis and CCR2+ myeloid cells","volume":"17","author":"Zhan","year":"2020","journal-title":"Cellular & Molecular Immunology"},{"key":"10.1016\/bs.ircmb.2024.05.002_bib190","first-page":"133","article-title":"Recent advances in the discovery and development of CCR1 antagonists","volume":"48","author":"Zhang","year":"2013"},{"issue":"14","key":"10.1016\/bs.ircmb.2024.05.002_bib191","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.cell.2022.05.022","article-title":"Humoral and cellular immune memory to four COVID-19 vaccines","volume":"185","author":"Zhang","year":"2022","journal-title":"Cell"},{"issue":"1","key":"10.1016\/bs.ircmb.2024.05.002_bib192","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/s41392-021-00734-w","article-title":"Pro-inflammatory microenvironment and systemic accumulation of CXCR3+ cell exacerbate lung pathology of old rhesus macaques infected with SARS-CoV-2","volume":"6","author":"Zheng","year":"2021","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"8","key":"10.1016\/bs.ircmb.2024.05.002_bib193","first-page":"e147","article-title":"Altered blood cell traits underlie a major genetic locus of severe COVID-19","volume":"76","author":"Zhou","year":"2021","journal-title":"The Journals of Gerontology: Series A"},{"issue":"5","key":"10.1016\/bs.ircmb.2024.05.002_bib194","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jinf.2023.02.022","article-title":"Enriched CXCR3+ CXCR5+ CD8+ T cells in SARS-CoV-2 infected and vaccinated individuals effectively respond to the antigen in recall","volume":"86","author":"Zhou","year":"2023","journal-title":"Journal of Infection"},{"issue":"12","key":"10.1016\/bs.ircmb.2024.05.002_bib195","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/s41422-021-00573-y","article-title":"Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms","volume":"31","author":"Zhu","year":"2021","journal-title":"Cell Research"},{"issue":"16","key":"10.1016\/bs.ircmb.2024.05.002_bib196","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1182\/blood-2010-02-258558","article-title":"Nomenclature of monocytes and dendritic cells in blood","volume":"116","author":"Ziegler-Heitbrock","year":"2010","journal-title":"Blood"},{"issue":"12","key":"10.1016\/bs.ircmb.2024.05.002_bib197","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/gb-2006-7-12-243","article-title":"The chemokine and chemokine receptor superfamilies and their molecular evolution","volume":"7","author":"Zlotnik","year":"2006","journal-title":"Genome Biology"}],"container-title":["International Review of Cell and Molecular Biology","Chemokine Receptors in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193764482400087X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S193764482400087X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T05:50:40Z","timestamp":1725947440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S193764482400087X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"ISBN":["9780443221729"],"references-count":197,"URL":"https:\/\/doi.org\/10.1016\/bs.ircmb.2024.05.002","relation":{},"ISSN":["1937-6448"],"issn-type":[{"value":"1937-6448","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]}}}